23/04/2026
The 2025 ESMO Congress in Berlin showcased important uro-oncology trials that may reshape treatment for bladder, prostate, and kidney cancers. Key findings from the Presidential Session highlighting the latest advances and potential new standards of care are summarized in this review paper.
Authors: Dawid Sigorski, Błażej Urbanowicz, Małgorzata Osmola, Michał Wilk